Posts by tag
CAR-T
From Imatinib to CAR-T: 20 Years of Leukaemia Progress
Advances in leukaemia treatment have accelerated from first-generation chemotherapy to precision targets and cellular immunotherapy. In this article, we summarise a paper by Robert Peter Gale, published in the OncoDaily Medical Journal, tracing that evolution across ALL, AML, CLL, and…
The unique toxicities of CAR-T cell therapy
The advent of chimeric antigen receptor T cell (CAR T cell) therapy generated great excitement in the field of onco-haematology. Clinical trials have shown remarkable results in patients with relapsed/refractory B cell malignancies, and two CAR T cell products…